Patheon having ‘Banner’ year, with boost from Latin America

Eric Palmer Lots of drug companies have been pointing to growth in emerging markets as a bright spot in their earnings reports. Now, Patheon can not only say it has seen growth from ...

FDA Asks for More Data on Heplisav

barbara.lempert Dynavax Reports Feedback From FDA Meeting Regarding HEPLISAV(TM) Biologic License Application Conference Call Scheduled for 9:00 a.m. ET Today BERKELEY, CA — ...

India’s Largest Pharmacy Chain Halts Sales Of Ranbaxy Drugs

esilverman Still more fallout from the Ranbaxy Laboratories manufacturing scandal. The latest setback for the beleaguered generic drugmaker is a decision by the largest pharmacy ...

Tweets of the day, 6/7/2013

chris.truelove   by Christiane Truelove (chris.truelove@ubm.com) For those who were watching yesterday, an FDA panel has voted to loosen the restrictions on Avandia. As Ed Silverman ...

Primary efficacy and safety data from four phase III Japanese studies of Simeprevir presented

barbara.lempert Primary efficacy and safety data from four phase III Japanese studies of Simeprevir presented at The Japan Society of Hepatology Stockholm, Sweden — Medivir AB (OMX: ...

Biotech vet Westphal to exit CEO post of cancer drug developer Verastem

Ryan McBride Verastem has changed CEOs as the company seeks to translate stem cell discoveries into powerful new cancer drugs. Biotech entrepreneur and Verastem co-founder Christoph ...

Impax whacks jobs to try to right itself after Rytary delays cost it GSK deal

Eric Palmer Impax Laboratories is cutting roughly 10% of its workforce, or 110 jobs, after problems at its manufacturing plant in California cost it FDA consideration of a drug application ...

Cardiac Insight Receives 510(k) Clearance for Wearable Monitor for Outpatient ECG Monitoring

barbara.lempert Cardiac Insight, Inc., a company focused on the diagnosis and treatment of cardiac arrhythmias, today announced it has received US Food and Drug Administration (FDA) ...

Johnson & Johnson takes rare gamble on microbiome science of biotech startup

Ryan McBride FierceBiotech News

Deregulation and More Efficient New Drug Approval Process set to Attract Foreign Investment in the Japanese Pharmaceutical Industry

barbara.lempert NEW YORK, LONDON, BERLIN, and PARIS, June 3, 2013 /PRNewswire/ — Japan’s pharmaceutical industry is the second largest in the world, worth $ 89 billion ...

‘Amazing Race’ Host Joins Novartis in MS Campaign

barbara.lempert TV Host Phil Keoghan and Novartis team up to inspire people with MS through innovative tandem cycling campaign — “Together in MS” tandem ...

FDA Grants Soligenix “Fast Track” Designation for SGX942

barbara.lempert for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer   Princeton, NJ – June 3, 2013 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS